首页> 外文OA文献 >Incidence of inpatient venous thromboembolism in treated patients with rheumatoid arthritis and the association with switching biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) in the real-world setting

【2h】

Incidence of inpatient venous thromboembolism in treated patients with rheumatoid arthritis and the association with switching biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) in the real-world setting

机译：病毒关节炎患者的入口静脉血栓栓塞的发病率和与现实世界环境中的转换生物学或靶向综合疾病改性抗胃（DMARDS）的关联

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Huifang Liang; Raghava Danwada; Dianlin Guo; Jeffrey R Curtis; Ryan D Kilpatrick; Barbara Hendrickson; Syed S Islam;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Original article: Incidence of inpatient venous thromboembolism in treated patients with rheumatoid arthritis and the association with switching biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) in the real-world setting [J] . Huifang Liang, Raghava Danwada, Dianlin Guo, RMD Open . 2019,第2期

机译：原始文章：治疗类风湿性关节炎患者的住院静脉血栓栓塞发生率，以及与在现实环境中转换生物制剂或靶向合成疾病修饰抗风湿药（DMARD）的关联
2. Availability of Clinical Measures for Patients with Rheumatoid Arthritis in Integrated Delivery Networks who Receive a Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drug: A Real-World Analysis of an Electronic Health Records Database [J] . Chastek Benjamin, Chen Chieh-I, Kimura Toshio, The Journal of rheumatology . 2018,第7期

机译：综合交付网络中的类风湿性关节炎患者的临床措施的可用性，受到生物或有针对性的合成疾病改性的抗漏毒药物的：对电子健康记录数据库的实际分析
3. Availability of Clinical Measures for Patients with Rheumatoid Arthritis in Integrated Delivery Networks who Receive a Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drug: A Real-World Analysis of an Electronic Health Records Database [J] . Chastek Benjamin, Chen Chieh-I, Kimura Toshio, The Journal of rheumatology . 2018,第7期

机译：综合交付网络中的类风湿性关节炎患者的临床措施的可用性，受到生物或有针对性的合成疾病改性的抗漏毒药物的：对电子健康记录数据库的实际分析
4. Original article: Incidence of inpatient venous thromboembolism in treated patients with rheumatoid arthritis and the association with switching biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) in the real-world setting [O] . Huifang Liang, Raghava Danwada, Dianlin Guo, 2019

机译：原始文章：类风湿关节炎患者的住院静脉血栓栓塞发生率以及与在现实环境中转换生物制剂或靶向合成疾病修饰抗风湿药（DMARDs）的关联
5. Real-World Persistence with Tocilizumab Compared to Other Subcutaneous Biologic Disease-Modifying Antirheumatic Drugs Among Patients with Rheumatoid Arthritis Switching from Another Biologic [O] . Jennie H. Best, Steven C. Vlad, Lenore Tominna, 2020

机译：与康康宫的现实世界持久与其他生物疾病改性患者的其他皮肤关节炎从另一个生物学切换的患者的抗触发药物相比

Incidence of inpatient venous thromboembolism in treated patients with rheumatoid arthritis and the association with switching biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) in the real-world setting

著录项

引文网络

相似文献

相关主题

期刊订阅